Inactive Instrument
Concert Pharmaceuticals, Inc. Stock
Stocks
CNCE
US2060221056
Biotechnology & Medical Research
| 1 day | +0.12% |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/6/23 A | Tender | Director | 128,448 | 0.2675% | ||
| 3/6/23 A | Tender | Chief Development Officer | 660,391 | 1.3752% | ||
| 3/6/23 A | Tender | Chief Legal Officer | 282,329 | 0.5879% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.12% | -0.36% | - | - | 521M | |
| -6.60% | -10.93% | +45.08% | +60.01% | 68.98B | |
| -4.09% | -0.11% | +2.31% | +54.81% | 53.15B | |
| +0.03% | +5.56% | +10.18% | +41.75% | 50.83B | |
| -2.63% | +1.64% | +28.38% | +32.75% | 44.61B | |
| -6.28% | -6.20% | +258.29% | +421.69% | 40.57B | |
| -1.32% | +4.15% | +16.08% | +112.24% | 42.53B | |
| +6.53% | +8.02% | +18.98% | +54.58% | 30.95B | |
| -0.90% | -10.91% | +34.11% | -1.83% | 25.44B | |
| -3.00% | -9.44% | -16.44% | -9.45% | 22.66B | |
| Average | -1.85% | +1.52% | +44.11% | +85.17% | 42.19B | |
| Weighted average by Cap. | -2.65% | +1.65% | +45.46% | +89.39% |
Employees
64
